Variant report
Variant | nsv460791 |
---|---|
Chromosome Location | chr3:102089007-102100781 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1435206 | chr3:102089007-102089008 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs531433424 | chr3:102089016-102089017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556371235 | chr3:102089028-102089029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549933121 | chr3:102089052-102089053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs76294422 | chr3:102089054-102089055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs190537896 | chr3:102089117-102089118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1435205 | chr3:102089118-102089119 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs182321711 | chr3:102089152-102089153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs544750376 | chr3:102089190-102089191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538791403 | chr3:102089221-102089222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536556638 | chr3:102089237-102089238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs368696560 | chr3:102089242-102089243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs145592737 | chr3:102089290-102089291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs184640897 | chr3:102089291-102089292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537126666 | chr3:102089307-102089308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs558815309 | chr3:102089331-102089332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs201146175 | chr3:102089347-102089348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs34204615 | chr3:102089354-102089355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577280808 | chr3:102089366-102089367 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542981429 | chr3:102089438-102089439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541036217 | chr3:102089456-102089457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs377233981 | chr3:102089474-102089475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545674712 | chr3:102089553-102089554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555392462 | chr3:102089564-102089565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs559699408 | chr3:102089566-102089567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs572362984 | chr3:102089567-102089568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573913811 | chr3:102089585-102089586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs370144092 | chr3:102089625-102089626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188954888 | chr3:102089626-102089627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7639553 | chr3:102089638-102089639 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs369685368 | chr3:102089655-102089656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549967119 | chr3:102089737-102089738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs564803118 | chr3:102089815-102089816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147676158 | chr3:102089855-102089856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs547036969 | chr3:102089863-102089864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565707742 | chr3:102089870-102089871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs181325878 | chr3:102089899-102089900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs371569854 | chr3:102089905-102089906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs562720058 | chr3:102089939-102089940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs548497423 | chr3:102089974-102089975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs142411014 | chr3:102090031-102090032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146501662 | chr3:102090062-102090063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559127034 | chr3:102090119-102090120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs185524620 | chr3:102090158-102090159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535162472 | chr3:102090221-102090222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs114230618 | chr3:102090225-102090226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs574916100 | chr3:102090241-102090242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs191415220 | chr3:102090256-102090257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs181036390 | chr3:102090267-102090268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs201601988 | chr3:102090288-102090289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21785460 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:102075600-102096600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr3:102093200-102093800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr3:102093200-102096600 | Weak transcription | HMEC | breast |
4 | chr3:102093800-102096400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr3:102096400-102097200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr3:102096400-102097200 | Enhancers | NHEK | skin |
7 | chr3:102096400-102098000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr3:102096600-102097600 | Enhancers | HMEC | breast |
9 | chr3:102096600-102098000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr3:102097200-102097600 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
11 | chr3:102097200-102097600 | Flanking Active TSS | NHEK | skin |
12 | chr3:102097600-102098600 | Enhancers | NHEK | skin |
13 | chr3:102099400-102099600 | Enhancers | Pancreatic Islets | Pancreatic Islet |